Brief: CytoTools Starts New European Clinical Trial In Indication Of Diabetic Foot Syndrome For DermaPro
Dec 21 (Reuters) - CYTOTOOLS AG T5OG.DE :
* STARTS NEW EUROPEAN CLINICAL TRIAL IN INDICATION OF
DIABETIC
FOOT SYNDROME FOR DERMAPRO
Source text for Eikon: ID:nEQklbk5a
Further company coverage: T5OG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on bioXXmed AG
See all newsBrief: CytoTools Announces Completion Of Capital Increase
Brief: CytoTools - Disputes Between CytoTools, DermaTools, Shareholders Ended
Brief: CytoTools Announces Retirement Of Two Members Of Management Board
Brief: CytoTools Sees Complete Change Of Management Board And Supervisory Board Possible
Lordstown Motors says hedge fund may buy up to $400 mln of its stock (updated)